Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Elvira Sanz named next president of Farmaindustria

Will lead Spanish pharma industry body for the new two years

Pfizer Spain Farmaindustria Elvira SanzSpanish pharmaceutical industry body Farmaindustria has selected Pfizer Spain's president and CEO Elvira Sanz to serve as its new president.

She will serve a two-year term and replaces Ferrer Grupo CEO Jordi Rementol, who took office in 2010.

Sanz has worked in the pharmaceutical industry for nearly 25 years, holding increasingly senior roles at Abelló, MSD, Roche and Cyanamid.

She became directorate general at Wyeth Spain in 2000 and was named president and CEO of Pfizer Spain in 2009.

Sanz takes up her new role at Farmaindustria at a time of increasing difficulties for the Spanish pharma industry, which has been hit hard by a series of government cost-containment measures and unpaid bills.

26th October 2012

From: Research, Sales, Marketing, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Medical Communications

dna: as different as you. Every patient, disease and therapy is di­fferent. As is every message, stakeholder and educational challenge....

Latest intelligence

Sharing our insights from the eyeforpharma, Barcelona 2016 patient track
A year on from the 'launch' of patient-centricity as a key theme at eyeforpharma and how have things progressed?...
An effective commercial model for cancer care
Patient-centric cancer care...
Blog_icon_understanding-the-adoption-ladder-in-closed-loop-marketing.png
Flexible content checklist – five questions to ask
To ensure that your content gets used by local markets and has a real impact, consider these questions when commissioning or developing core materials....

Infographics